title: Osteoimmunology: Wnt antagonists: for better or worse?
abstract: Molecules involved in developmental signaling pathways have emerged as therapeutic targets for various rheumatic diseases. New research sheds light on the consequences of interfering with these processes.
authors: Laboratory for Skeletal Development and Joint Disorders, Division of Rheumatology, Katholieke Universiteit Leuven, Leuven, Belgium.
authors: Rik J
authors: RJ
authors: Lories
authors: Frank P
authors: FP
authors: Luyten
mesh_terms: D000818:Animals; D018501:Antirheumatic Agents / Q000009:adverse effects*; D006801:Humans; D051379:Mice; D015398:Signal Transduction / Q000187:drug effects*; D025242:Spondylarthropathies / Q000188:drug therapy*; D051153:Wnt Proteins / Q000037:antagonists & inhibitors* / Q000378:metabolism
chemical_list: D018501:Antirheumatic Agents; D051153:Wnt Proteins